+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia-Pacific IVF Services Market by Cycle Type, Thawed IVF Cycles, and Donor Egg IVF Cycles), and End User - Global Opportunity Analysis and Industry Forecast, 2018-2028

  • ID: 4621175
  • Report
  • July 2018
  • Region: Global, Asia Pacific
  • 369 pages
  • Allied Analytics LLP
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Apollo Hospitals Dhaka
  • CHA Fertility Center
  • Fertility Associates
  • IVF Van Hanh
  • Maria Fertility Hospital
  • Repromed
  • MORE

In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a woman’s ovaries and fertilizing them with sperm outside the body, in vitro. The Asia-Pacific IVF services revenue market generated $3,734 million in 2017 and is projected to reach $13,669 million by 2028, growing at a CAGR of 12.4% from 2018 to 2028.

The Asia-Pacific IVF services market is anticipated to exhibit significant market growth during the forecast period, owing to rise in infertility rate, increase in trend of delayed pregnancies, surge in IVF success rate, and rise in disposable income in the Asia-Pacific region. However, complications associated with IVF treatment, and low awareness level for IVF in some under developed regions hinder the growth of the market. Conversely, upsurge in fertility tourism, increase in number of fertility clinics, and growth opportunities in the emerging markets make way for market development in the future.

The Asia-Pacific IVF services market is segmented based on cycle type, end user, and country. Based on cycle type, the market is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. According to end user, the market is classified as fertility clinics, hospitals, surgical centers and clinical research institutes. Country wise, the market is studied across India, China, Japan, Australia, New Zealand, South Korea, Thailand, Singapore, Malaysia, Indonesia, Philippines, Vietnam, Myanmar, and Rest of Asia-Pacific.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2028, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Cycle Type

Fresh IVF Cycles (Non-Donor)
Thawed IVF Cycles (Non-Donor)
Donor Egg IVF Cycles

By End User

Fertility Clinics
Hospitals
Surgical centers
Clinical research institutes

By Country

India
China
Japan
Australia
New Zealand
South Korea
Thailand
Singapore
Malaysia
Indonesia
Philippines
Vietnam
Myanmar
Rest of Asia-Pacific

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Apollo Hospitals Dhaka
Australian Concept Infertility Medical Center (ACIMC)
Bahosi Fertility Centre
Bangkok IVF center
Bloom Fertility and Healthcare
Bloom Fertility Center
Bourn Hall Fertility Center
Bumrungrad International Hospital
Center for Advanced Reproductive Medicine and Infertility
CHA Fertility Center
Chennai Fertility Center
Cloudnine Fertility
Damai Service Hospital
Fatemieh Infertility Center
Fertility Associates
Fertility Centre Nepal (Part of Wecare Health Services, India)
Fertility First
Flinders Reproductive Medicine Pty Ltd
Genea Oxford Fertility Limited
IHH Healthcare Berhad
IVF NAMBA Clinic
IVF Sri Lanka Life Plus (Pvt) Ltd
IVF Van Hanh
KL Fertility & Gynecology Centre
Lanka Hospitals
LIFE – Lahore Institute of Fertility & Endocrinology
Lotus Fertility Clinic
Manipal Fertility
Maria Fertility Hospital
MEHR IVF Clinic
Monash IVF Wesley Hospital Auchenflower
Morpheus Life Sciences Pvt. Ltd.
Morula IVF
National University Hospital
Nepal International Fertility Centre
Oak Medical Group/Oak Clinic
Raffles Medical Group
Repromed
RSUP Dr. Hasan Sadikin Bandung
SAFE Fertility Center
Sanno Hospital
Saqib Fertility & IVF Center – Mid City Hospital
Shanghai Ji Ai Genetics & IVF Institute
Shanghai United Family Hospital
Southend Fertility and IVF
Superior A.R.T Myanmar
Thomson Medical Pte. Ltd.
TMC Fertility Centre
Tu Du Hospital
Victory A.R.T. Laboratory Phils., Inc.
Virtus Health

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Apollo Hospitals Dhaka
  • CHA Fertility Center
  • Fertility Associates
  • IVF Van Hanh
  • Maria Fertility Hospital
  • Repromed
  • MORE
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Asia-Pacific IVF Services Market, By End User
3.2.1. Market size and forecast
3.2.2. Market volume and forecast
3.2.3. Fertility clinics
3.2.3.1. Market size and forecast
3.2.4. Hospitals
3.2.4.1. Market size and forecast
3.2.5. Surgical centers
3.2.5.1. Market size and forecast
3.2.6. Clinical research institutes
3.2.6.1. Market size and forecast
3.3. Asia-Pacific IVF Services Market, by Cycle Type
3.3.1. Market size and forecast
3.3.2. Market volume and forecast
3.3.3. Fresh IVF cycles (non-donor)
3.3.3.1. Market size and forecast
3.3.4. Thawed IVF cycles (non-donor)
3.3.4.1. Market size and forecast
3.3.5. Donor egg IVF cycles
3.3.5.1. Market size and forecast
3.4. Asia-Pacific IVF services market, by country
3.4.1. Market size and forecast
3.4.2. Market volume and forecast
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Delayed pregnancies in women
3.5.1.2. Increase in global infertility rates
3.5.1.3. Increase in gamete donations
3.5.1.4. Increase in disposable income
3.5.1.5. Increase in IVF success rates
3.5.2. Restraints
3.5.2.1. Complications associated with IVF treatment
3.5.2.2. Low awareness level
3.5.3. Opportunities
3.5.3.1. Fertility tourism
3.5.3.2. Growth opportunities in the Asia-Pacific region
3.5.3.3. Increase in number of fertility clinics
3.5.4. Impact analyses

CHAPTER 4: INDIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
4.1. Overview
4.1.1. Market size and forecast
4.2. Fertility Center in India
4.3. India IVF Services Market, By End User
4.3.1. Market size and forecast
4.3.2. Market volume and forecast
4.3.3. Fertility clinics
4.3.4. Hospitals
4.3.5. Surgical centers
4.3.6. Clinical research institutes
4.4. India IVF Services Market, By Cycle Type
4.4.1. Market size and forecast
4.4.2. Market volume and forecast
4.4.3. Fresh IVF cycles (non-donor)
4.4.4. Thawed IVF cycles (non-donor)
4.4.5. Donor egg IVF cycles
4.5. Market Dynamics
4.5.1. Driving factors
4.5.2. Restraining factors
4.6. Regulatory Issues, Legislations and Authorities
4.7. Insurance Reimbursement Scenario
4.8. Company Profiles
4.8.1. Bourn Hall Fertility Center
4.8.1.1. Company overview
4.8.2. Southend Fertility and IVF
4.8.2.1. Company overview
4.8.3. Morpheus Life Sciences Pvt. Ltd.
4.8.3.1. Company overview
4.8.4. Bloom Fertility Center
4.8.4.1. Company overview
4.8.5. Bloom Fertility and Healthcare
4.8.5.1. Company overview
4.8.6. Manipal Fertility
4.8.6.1. Company overview
4.8.7. Cloudnine Fertility
4.8.7.1. Company overview
4.8.8. Chennai Fertility Center
4.8.8.1. Company overview

CHAPTER 5: CHINA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
5.1. Overview
5.1.1. Market size and forecast
5.2. China IVF Services Market, By End User
5.2.1. Market size and forecast
5.2.2. Market volume and forecast
5.2.3. Fertility clinics
5.2.4. Hospitals
5.2.5. Surgical centers
5.2.6. Clinical research institutes
5.3. China IVF Services Market, By Cycle Type
5.3.1. Market size and forecast
5.3.2. Market volume and forecast
5.3.3. Fresh IVF cycles (non-donor)
5.3.4. Thawed IVF cycles (non-donor)
5.3.5. Donor egg IVF cycles
5.4. Market Dynamics
5.4.1. Driving factors
5.4.2. Restraining Factors
5.5. Regulatory Issues, Legislations and Authorities
5.6. Insurance Reimbursement Scenario
5.7. Company Profiles
5.7.1. Shanghai Ji Ai Genetics & IVF Institute
5.7.1.1. Company overview
5.7.2. Shanghai United Family Hospital
5.7.2.1. Company overview

CHAPTER 6: JAPAN IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
6.1. Overview
6.1.1. Market size and forecast
6.2. Japan IVF Services Market, By End User
6.2.1. Market size and forecast
6.2.2. Market volume and forecast
6.2.3. Fertility clinics
6.2.4. Hospitals
6.2.5. Surgical centers
6.2.6. Clinical research institutes
6.3. Japan IVF Services Market, By Cycle Type
6.3.1. Market size and forecast
6.3.2. Market volume and forecast
6.3.3. Fresh IVF cycles (non-donor)
6.3.4. Thawed IVF cycles (non-donor)
6.3.5. Donor egg IVF cycles
6.4. Market Dynamics
6.4.1. Driving factors
6.4.2. Restraining Factors
6.5. Regulatory Issues, Legislations and Authorities
6.6. Insurance Reimbursement Scenario
6.7. Company Profiles
6.7.1. IVF NAMBA Clinic
6.7.1.1. Company overview
6.7.2. Sanno Hospital
6.7.2.1. Company overview
6.7.3. Oak Medical Group/Oak Clinic
6.7.3.1. Company overview

CHAPTER 7: AUSTRALIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
7.1. Overview
7.1.1. Market size and forecast
7.2. Fertility Center in Australia
7.3. Australia IVF Services Market, By End User
7.3.1. Market size and forecast
7.3.2. Market volume and forecast
7.3.3. Fertility clinics
7.3.4. Hospitals
7.3.5. Surgical centers
7.3.6. Clinical research institutes
7.4. Australia IVF Services Market, By Cycle Type
7.4.1. Market size and forecast
7.4.2. Market volume and forecast
7.4.3. Fresh IVF cycles (non-donor)
7.4.4. Thawed IVF cycles (non-donor)
7.4.5. Donor egg IVF cycles
7.5. Market Dynamics
7.5.1. Driving factors
7.5.2. Restraining Factors
7.6. Regulatory Issues, Legislations and Authorities
7.7. Insurance Reimbursement Scenario
7.8. Company Profiles
7.8.1. Virtus Health
7.8.1.1. Company overview
7.8.2. Monash IVF Wesley Hospital Auchenflower
7.8.2.1. Company overview
7.8.3. Fertility First
7.8.3.1. Company overview
7.8.4. Flinders Reproductive Medicine Pty Ltd
7.8.4.1. Company overview

CHAPTER 8: NEW ZEALAND IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
8.1. Overview
8.1.1. Market size and forecast
8.2. New Zealand IVF Services Market, By End User
8.2.1. Market size and forecast
8.2.2. Market volume and forecast
8.2.3. Fertility clinics
8.2.4. Hospitals
8.2.5. Surgical centers
8.2.6. Clinical research institutes
8.3. New Zealand IVF Services Market, By Cycle Type
8.3.1. Market size and forecast
8.3.2. Market volume and forecast
8.3.3. Fresh IVF cycles (non-donor)
8.3.4. Thawed IVF cycles (non-donor)
8.3.5. Donor egg IVF cycles
8.4. Market Dynamics
8.4.1. Driving factors
8.4.2. Restraining Factors
8.5. Regulatory Issues, Legislations and Authorities
8.6. Insurance Reimbursement Scenario
8.7. Company Profiles
8.7.1. Fertility Associates
8.7.1.1. Company overview
8.7.2. Genea Oxford Fertility Limited
8.7.2.1. Company overview
8.7.3. Repromed
8.7.3.1. Company overview

CHAPTER 9: SOUTH KOREA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
9.1. Overview
9.1.1. Market size and forecast
9.2. Fertility Center in South Korea
9.3. South Korea IVF Services Market, By End User
9.3.1. Market size and forecast
9.3.2. Market volume and forecast
9.3.3. Fertility clinics
9.3.4. Hospitals
9.3.5. Surgical centers
9.3.6. Clinical research institutes
9.4. South Korea IVF Services Market, By Cycle Type
9.4.1. Market size and forecast
9.4.2. Market volume and forecast
9.4.3. Fresh IVF cycles (non-donor)
9.4.4. Thawed IVF cycles (non-donor)
9.4.5. Donor egg IVF cycles
9.5. Market Dynamics
9.5.1. Driving factors
9.5.2. Restraining Factors
9.6. Regulatory Issues, Legislations and Authorities
9.7. Insurance Reimbursement Scenario
9.8. Company Profiles
9.8.1. CHA Fertility Center
9.8.1.1. Company overview
9.8.2. Maria Fertility Hospital
9.8.2.1. Company overview

CHAPTER 10: THAILAND IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
10.1. Overview
10.1.1. Market size and forecast
10.2. Thailand IVF Services Market, By End User
10.2.1. Market size and forecast
10.2.2. Market volume and forecast
10.2.3. Fertility clinics
10.2.4. Hospitals
10.2.5. Surgical centers
10.2.6. Clinical research institutes
10.3. Thailand IVF Services Market, By Cycle Type
10.3.1. Market size and forecast
10.3.2. Market volume and forecast
10.3.3. Fresh IVF cycles (non-donor)
10.3.4. Thawed IVF cycles (non-donor)
10.3.5. Donor egg IVF cycles
10.4. Market Dynamics
10.4.1. Driving factors
10.4.2. Restraining Factors
10.5. Regulatory Issues, Legislations and Authorities
10.6. Insurance Reimbursement Scenario
10.7. Company Profiles
10.7.1. SAFE Fertility Center
10.7.1.1. Company overview
10.7.2. Bangkok IVF Center (Bangkok Hospital)
10.7.2.1. Company overview
10.7.3. Bangkok IVF center
10.7.3.1. Company overview

CHAPTER 11: SINGAPORE IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
11.1. Overview
11.1.1. Market size and forecast
11.2. Singapore IVF Services Market, By End User
11.2.1. Market size and forecast
11.2.2. Market volume and forecast
11.2.3. Fertility clinics
11.2.4. Hospitals
11.2.5. Surgical centers
11.2.6. Clinical research institutes
11.3. Singapore IVF Services Market, By Cycle Type
11.3.1. Market size and forecast
11.3.2. Market volume and forecast
11.3.3. Fresh IVF cycles (non-donor)
11.3.4. Thawed IVF cycles (non-donor)
11.3.5. Donor egg IVF cycles
11.4. Market Dynamics
11.4.1. Driving factors
11.4.2. Restraining factors
11.5. Regulatory Issues, Legislations and Authorities
11.6. Insurance Reimbursement Scenario
11.7. Company Profiles
11.7.1. National University Hospital
11.7.1.1. Company overview
11.7.2. IHH Healthcare Berhad
11.7.2.1. Company overview
11.7.3. Thomson Medical Pte. Ltd.
11.7.3.1. Company overview
11.7.4. Raffles Medical Group
11.7.4.1. Company overview

CHAPTER 12: MALAYSIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
12.1. Overview
12.1.1. Market size and forecast
12.2. Malaysia IVF Services Market, By End User
12.2.1. Market size and forecast
12.2.2. Market volume and forecast
12.2.3. Fertility clinics
12.2.4. Hospitals
12.2.5. Surgical centers
12.2.6. Clinical research institutes
12.3. Malaysia IVF Services Market, By Cycle Type
12.3.1. Market size and forecast
12.3.2. Market volume and forecast
12.3.3. Fresh IVF cycles (non-donor)
12.3.4. Thawed IVF cycles (non-donor)
12.3.5. Donor egg IVF cycles
12.4. Market Dynamics
12.4.1. Driving factors
12.4.2. Restraining factors
12.5. Regulatory Issues, Legislations and Authorities
12.6. Insurance Reimbursement Scenario
12.7. Company Profiles
12.7.1. Damai Service Hospital
12.7.1.1. Company overview
12.7.2. TMC Fertility Centre
12.7.2.1. Company overview
12.7.3. KL Fertility & Gynecology Centre
12.7.3.1. Company overview

CHAPTER 13: INDONESIA IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
13.1. Overview
13.1.1. Market size and forecast
13.2. Indonesia IVF Services Market, By End User
13.2.1. Market size and forecast
13.2.2. Market volume and forecast
13.2.3. Fertility clinics
13.2.4. Hospitals
13.2.5. Surgical centers
13.2.6. Clinical research institutes
13.3. Indonesia IVF Services Market, By Cycle Type
13.3.1. Market size and forecast
13.3.2. Market volume and forecast
13.3.3. Fresh IVF cycles (non-donor)
13.3.4. Thawed IVF cycles (non-donor)
13.3.5. Donor egg IVF cycles
13.4. Market Dynamics
13.4.1. Driving factors
13.4.2. Restraining factors
13.5. Regulatory Issues, Legislations and Authorities
13.6. Insurance Reimbursement Scenario
13.7. Company Profiles
13.7.1. Morula IVF
13.7.1.1. Company overview
13.7.2. Lotus Fertility Clinic
13.7.2.1. Company overview
13.7.3. RSUP Dr. Hasan Sadikin Bandung
13.7.3.1. Company overview

CHAPTER 14: PHILIPPINES IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
14.1. Overview
14.1.1. Market size and forecast
14.2. Philippines IVF Services Market, By End User
14.2.1. Market size and forecast
14.2.2. Market volume and forecast
14.2.3. Fertility clinics
14.2.4. Hospitals
14.2.5. Surgical centers
14.2.6. Clinical research institutes
14.3. Philippines IVF Services Market, By Cycle Type
14.3.1. Market size and forecast
14.3.2. Market volume and forecast
14.3.3. Fresh IVF cycles (non-donor)
14.3.4. Thawed IVF cycles (non-donor)
14.3.5. Donor egg IVF cycles
14.4. Market Dynamics
14.4.1. Driving factors
14.4.2. Restraining factors
14.5. Regulatory Issues, Legislations and Authorities
14.6. Insurance Reimbursement Scenario
14.7. Company Profiles
14.7.1. Victory A.R.T. Laboratory Phils., Inc.
14.7.1.1. Company overview
14.7.2. Center for Advanced Reproductive Medicine and Infertility
14.7.2.1. Company overview

CHAPTER 15: VIETNAM IVF SERVICES MARKET, (REVENUE AND NUMBER OF CYCLES)
15.1. Overview
15.1.1. Market size and forecast
15.2. Vietnam IVF Services Market, By End User
15.2.1. Market size and forecast
15.2.2. Market volume and forecast
15.2.3. Fertility clinics
15.2.4. Hospitals
15.2.5. Surgical centers
15.2.6. Clinical research institutes
15.3. Vietnam IVF Services Market, By Cycle Type
15.3.1. Market size and forecast
15.3.2. Market volume and forecast
15.3.3. Fresh IVF cycles (non-donor)
15.3.4. Thawed IVF cycles (non-donor)
15.3.5. Donor egg IVF cycles
15.4. Market Dynamics
15.4.1. Driving factors
15.4.2. Restraining factors
15.5. Regulatory Issues, Legislations and Authorities
15.6. Insurance Reimbursement Scenario
15.7. Company Profiles
15.7.1. IVF Van Hanh
15.7.1.1. Company overview
15.7.2. Tu Du Hospital
15.7.2.1. Company overview

CHAPTER 16: MYANMAR IVF SERVICES MARKET (REVENUE AND NUMBER OF CYCLES)
16.1. Overview
16.2. Market size and forecast
16.3. Myanmar IVF Services Market, By End User
16.3.1. Market size and forecast
16.3.2. Market volume and forecast
16.3.3. Fertility clinics
16.3.4. Hospitals
16.3.5. Surgical centers
16.3.6. Clinical research institutes
16.4. Myanmar IVF Services Market, By Cycle Type
16.4.1. Market size and forecast
16.4.2. Market volume and forecast
16.4.3. Fresh IVF cycles (non-donor)
16.4.4. Thawed IVF cycles (non-donor)
16.5. Market Dynamics
16.5.1. Driving factors
16.5.2. Restraining factors
16.6. Regulatory issues, legislations, and authorities
16.7. Insurance Reimbursement Scenario
16.8. Company Profiles
16.8.1. Bahosi Fertility Centre
16.8.1.1. Company overview
16.8.2. Bumrungrad International Hospital
16.8.2.1. Company overview
16.8.3. Superior A.R.T Myanmar
16.8.3.1. Company overview

CHAPTER 17: REST OF ASIA-PACIFIC IVF SERVICES MARKET (REVENUE AND NUMBER OF CYCLES)
17.1. Overview
17.1.1. Market size and forecast
17.2. Rest of Asia-Pacific IVF Services Market, By End User
17.2.1. Market size and forecast
17.2.2. Market volume and forecast
17.2.3. Fertility clinics
17.2.4. Hospitals
17.2.5. Surgical centers
17.2.6. Clinical research institutes
17.3. Rest of Asia-Pacific IVF Services Market, By Cycle Type
17.3.1. Market size and forecast
17.3.2. Market volume and forecast
17.3.3. Fresh IVF cycles (non-donor)
17.3.4. Thawed IVF cycles (non-donor)
17.3.5. Donor egg IVF cycles
17.4. Market Dynamics
17.4.1. Driving factors
17.4.2. Restraining factors
17.5. Regulatory issues, legislations, and authorities
17.6. Insurance Reimbursement Scenario
17.7. Company Profiles
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Apollo Hospitals Dhaka
  • CHA Fertility Center
  • Fertility Associates
  • IVF Van Hanh
  • Maria Fertility Hospital
  • Repromed
  • MORE

According to a new report titled, "Asia-Pacific IVF Services Market, by Cycle Type, and End User: Opportunity Analysis and Industry Forecast, 2018-2028" the market generated $3,734 million in 2017 and is projected to reach $13,669 million by 2028, growing at a CAGR of 12.4% from 2018 to 2028.

In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely used treatments, which assisted couples with infertility problems, single mothers, and the LGBT community to procreate. Increase in infertility rate, rise in trend of delayed pregnancies, surge in IVF success rate, and growth in disposable income in Asia-Pacific region drive the growth of the IVF services market. However, the market growth is restricted by complications associated with IVF treatment, and low awareness level for IVF in some under developed regions.

Based on cycle-type, the fresh cycle (non-donor) segment is major revenue contributor and is expected to dominate the market during the forecast period.

Depending on end user, the Asia-Pacific IVF services market is dominated by the fertility clinics segment and is estimated to continue this trend during the forecast period, due to low cost of treatment and increase in number of fertility clinics.

Key Findings of the Asia-Pacific IVF Services Market:

  • Fresh IVF cycle (non-donor) segment is expected to grow at a significant CAGR of 12.9% (in terms of value) from 2018 to 2028
  • Japan generated the highest revenue in the Asia-Pacific IVF services market in 2017 accounting for nearly half of the market share in 2017
  • Japan witnessed the highest number of IVF treatments accounting for nearly two-fifths of the total cycles in 2017 and is expected to remain so throughout the forecast period
  • India is expected to register the highest CAGR of 15.3% (in terms of value) throughout the forecast period

The list of key players profiled in this report include Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bangkok IVF center, Bloom Fertility and Healthcare, Bloom Fertility Center, Bourn Hall Fertility Center, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, Chennai Fertility Center, Cloudnine Fertility, Damai Service Hospital, Fatemieh Infertility Center, Fertility Associates, Fertility Centre Nepal (Part of Wecare Health Services, India), Fertility First, Flinders Reproductive Medicine Pty Ltd, Genea Oxford Fertility Limited, IHH Healthcare Berhad, IVF NAMBA Clinic, IVF Sri Lanka Life Plus (Pvt) Ltd, IVF Van Hanh, KL Fertility & Gynecology Centre, Lanka Hospitals, LIFE Lahore Institute of Fertility & Endocrinology, Lotus Fertility Clinic, Manipal Fertility, Maria Fertility Hospital, MEHR IVF Clinic, Monash IVF Wesley Hospital Auchenflower, Morpheus Life Sciences Pvt. Ltd., Morula IVF, National University Hospital, Nepal International Fertility Centre, Oak Medical Group/Oak Clinic, Raffles Medical Group, Repromed, RSUP Dr. Hasan Sadikin Bandung, SAFE Fertility Center, Sanno Hospital, Saqib Fertility & IVF Center Mid City Hospital, Shanghai Ji Ai Genetics & IVF Institute, Shanghai, United Family Hospital, Southend Fertility and IVF, Superior A.R.T Myanmar, Thomson Medical Pte. Ltd., TMC Fertility Centre, Tu Du Hospital, Victory A.R.T. Laboratory Phils., Inc., and Virtus Health.

Note: Product cover images may vary from those shown
5 of 5
  • Apollo Hospitals Dhaka
  • Australian Concept Infertility Medical Center (ACIMC)
  • Bahosi Fertility Centre
  • Bangkok IVF center
  • Bloom Fertility and Healthcare
  • Bloom Fertility Center
  • Bourn Hall Fertility Center
  • Bumrungrad International Hospital
  • Center for Advanced Reproductive Medicine and Infertility
  • CHA Fertility Center
  • Chennai Fertility Center
  • Cloudnine Fertility
  • Damai Service Hospital
  • Fatemieh Infertility Center
  • Fertility Associates
  • Fertility Centre Nepal (Part of Wecare Health Services India)
  • Fertility First
  • Flinders Reproductive Medicine Pty Ltd
  • Genea Oxford Fertility Limited
  • IHH Healthcare Berhad
  • IVF NAMBA Clinic
  • IVF Sri Lanka Life Plus (Pvt) Ltd
  • IVF Van Hanh
  • KL Fertility & Gynecology Centre
  • Lanka Hospitals
  • LIFE Lahore Institute of Fertility & Endocrinology
  • Lotus Fertility Clinic
  • Manipal Fertility
  • Maria Fertility Hospital
  • MEHR IVF Clinic
  • Monash IVF Wesley Hospital Auchenflower
  • Morpheus Life Sciences Pvt. Ltd.
  • Morula IVF
  • National University Hospital
  • Nepal International Fertility Centre
  • Oak Medical Group/Oak Clinic
  • Raffles Medical Group
  • Repromed
  • RSUP Dr. Hasan Sadikin Bandung
  • SAFE Fertility Center
  • Sanno Hospital
  • Saqib Fertility & IVF Center Mid City Hospital
  • Shanghai Ji Ai Genetics & IVF Institute
  • United Family Hospital
  • Southend Fertility and IVF
  • Superior A.R.T Myanmar
  • Thomson Medical Pte. Ltd.
  • TMC Fertility Centre
  • Tu Du Hospital
  • Victory A.R.T. Laboratory Phils. Inc.
  • Virtus Health
Note: Product cover images may vary from those shown
6 of 5

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll